10-Q: H.B. Fuller Q1 2026 Earnings Rise Amidst Revenue Dip

H.B. Fuller Company reported a significant increase in net income and diluted EPS for Q1 2026, despite a slight decrease in net revenue, driven by improved gross profit margins and strategic acquisitions.

Summary

• Net income attributable to H.B. Fuller increased by 59.1% to $21.0 million in Q1 2026, up from $13.2 million in Q1 2025.
• Diluted earnings per share rose to $0.38 in Q1 2026, compared to $0.24 in Q1 2025.
• Net revenue decreased by 2.3% to $770.8 million in Q1 2026 from $788.7 million in Q1 2025, primarily due to a 7.2% decrease in sales volume.
• Gross profit margin improved by 180 basis points to 30.6% in Q1 2026, driven by higher product pricing, lower raw material costs, and the impact of acquisitions.
• Adjusted EBITDA increased by 3.8% to $118.7 million in Q1 2026, with the Adjusted EBITDA margin expanding by 90 basis points to 15.4%.
• The company initiated new restructuring actions for global footprint optimization in Q1 2026, with expected pre-tax costs of $10.2 million to $12.2 million.
• Net cash used in operating activities significantly improved to $4.0 million in Q1 2026 from $52.9 million in Q1 2025.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, primarily due to strong profit growth and margin expansion despite a revenue decline, indicating effective cost management and strategic benefits from acquisitions. The improved operating cash flow is also a significant positive.

Positives

• Net income attributable to H.B. Fuller increased by 59.1% to $21.0 million in Q1 2026.
• Diluted earnings per share rose to $0.38 in Q1 2026 from $0.24 in Q1 2025.
• Gross profit margin improved by 180 basis points to 30.6% due to higher pricing, lower raw material costs, and acquisitions.
• Adjusted EBITDA increased by 3.8% to $118.7 million, with a 90 basis point expansion in Adjusted EBITDA margin.
• Net cash used in operating activities significantly improved from $52.9 million in Q1 2025 to $4.0 million in Q1 2026.
• The company remains in compliance with all credit agreement covenants, with a Secured Total Indebtedness / TTM EBITDA ratio of 2.3 (vs. limit of 4.50) and TTM EBITDA / Consolidated Interest Expense of 5.0 (vs. limit of 2.0).
• Income from equity method investments increased by 80.0% to $0.9 million, reflecting higher net income from the Sekisui-Fuller joint venture.

Negatives

• Net revenue decreased by 2.3% to $770.8 million in Q1 2026.
• Sales volume decreased by 7.2% in Q1 2026 compared to Q1 2025.
• Selling, general and administrative (SG&A) expenses increased by 2.2% to $184.5 million, rising 100 basis points as a percentage of net revenue.
• Free cash flow remained negative at $(61.7) million in Q1 2026, although an improvement from $(85.9) million in Q1 2025.
• Purchases of property, plant and equipment increased to $57.7 million in Q1 2026 from $33.0 million for the same period in 2025.
• Organic revenue growth decreased across all segments: Hygiene, Health and Consumable Adhesives (-10.1%), Building Adhesive Solutions (-5.1%), and Engineering Adhesives (-2.0%).

Risks

• Uncertainties exist with respect to the amounts and timing of ultimate environmental liabilities.
• Adverse developments and/or periodic settlements in legal proceedings, including asbestos-related litigation, could negatively impact results of operations or cash flows in one or more future periods.
• Exposure to various market risks, including changes in interest rates, foreign currency rates, and prices of raw materials.
• The company's credit agreements include restrictive covenants that, if not met, could lead to renegotiation of credit lines and a significant increase in financing costs.
• The company does not undertake responsibility for updating forward-looking information, which is subject to risks and uncertainties.

Future Outlook

The company expects remaining cash payments for fiscal year 2023 restructuring plans to continue into fiscal year 2026. New global footprint optimization restructuring actions, approved in Q1 2026, are expected to be completed during fiscal year 2028, with the majority of charges and cash payments occurring in fiscal 2026 and 2027. The company believes cash flows from operating activities will be adequate to meet short-term and long-term liquidity and capital expenditure needs and has the ability to obtain both short-term and long-term debt for foreseeable financing needs.

Management Comments

• We believe that cash flows from operating activities will be adequate to meet our short-term and long-term liquidity and capital expenditure needs.
• We believe we have the ability to obtain both short-term and long-term debt to meet our financing needs for the foreseeable future.
• Cash available in the United States has historically been sufficient and we expect it will continue to be sufficient to fund U.S. operations, U.S. capital spending and U.S. pension and other postretirement benefit contributions in addition to funding U.S. acquisitions, dividend payments, debt service and share repurchases as needed.
• For those international earnings considered to be reinvested indefinitely, we currently have no intention to, and plans do not indicate a need to, repatriate these funds for U.S. operations.
• We believe we have the ability to meet all of our contractual obligations and commitments for the next twelve months.

Industry Context

StockSavvy.ai notes that H.B. Fuller's performance reflects a mixed industry environment. While organic revenue declined due to lower sales volumes, the company's ability to increase gross profit margins through pricing and raw material cost management, coupled with strategic acquisitions, indicates resilience in a challenging market. The positive currency effects also highlight the benefits of a diversified global presence, a common theme among leading specialty chemical and adhesive manufacturers navigating regional economic variations.

Legal Proceedings

• Environmental investigations and clean-up activities with liabilities of $2.666 million as of February 28, 2026, not expected to have a material adverse effect.
• Asbestos-related lawsuits, with 2 claims settled for $258,000 in Q1 2026, largely offset by $192,000 in expected insurance payments, not expected to have a material adverse effect.
• Proposed settlement of Rouse et al. v. H.B. Fuller Company et al. for up to $75.0 million related to alleged grout defects, with an accrual of $34.8 million recorded and expected substantial insurance reimbursement.

Stakeholder Impact

• Shareholders: Positive impact from increased net income and EPS, improved gross profit margins, and ongoing share repurchase program (though no repurchases in current quarter).
• Employees: Impacted by ongoing restructuring plans, including severance and related costs, but also benefit from share-based compensation plans.
• Customers: Potentially impacted by product pricing adjustments and changes in product offerings due to acquisitions and restructuring.
• Creditors: Positive impact from compliance with debt covenants and management's belief in adequate liquidity and ability to obtain financing.

Next Steps

• Continue cash payments for fiscal year 2023 restructuring plans into fiscal year 2026.
• Implement new global footprint optimization restructuring actions, with majority of charges and cash payments in fiscal 2026 and 2027, and expected completion by fiscal year 2028.
• Pursue reimbursement from insurers for a substantial portion of the Rouse et al. lawsuit settlement amount and legal fees.

Key Dates

Recommendation

The company demonstrated strong profit growth and margin expansion, indicating effective operational management and strategic benefits from recent acquisitions. However, the decline in net revenue driven by lower sales volume across all segments, coupled with negative free cash flow, suggests underlying demand challenges. While the financial health is improving, the revenue headwinds warrant a cautious 'hold' stance until a clearer trend of organic revenue growth emerges.

Keywords

H.B. Fuller, FUL, Quarterly Report, 10-Q, Adhesives, Sealants, Financial Results, Earnings, EBITDA, Gross Profit, Net Revenue, Restructuring, Acquisitions, Cash Flow, Debt, Share Repurchase, SEC Filing, Industrial Materials, Specialty Chemicals